Literature DB >> 20490741

Musculoskeletal pain associated with corticosteroid therapy in cancer.

Deborah A Frieze1.   

Abstract

Corticosteroids have multiple uses in the care of the cancer patient. Although they confer benefit to the patient, high doses and extended duration of use may lead to significant adverse effects. Adverse effects such as osteoporosis-induced fractures, osteonecrosis, myopathy and myalgias can cause significant pain and have a negative impact on the patient's quality of life. In this paper, I will review the mechanisms involved in the toxicity, risk factors, prevalence, prevention, and treatment strategies.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20490741     DOI： 10.1007/s11916-010-0120-z

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN： 1534-3081


  28 in total

1.  Avascular necrosis of the femoral head after treatment of Hodgkin's disease.

Authors:  V Tombolini; A Capua; E Pompili
Journal:  Acta Oncol       Date:  1992       Impact factor: 4.089

2.  The use of nasal calcitonin spray in the treatment of hypercalcaemia of malignancy.

Authors:  M Bower; R C Stein; A Hedley; J Davenport; K Colston; R C Coombes
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 3.  Mechanisms of glucocorticoid-induced myopathy.

Authors:  O Schakman; H Gilson; J P Thissen
Journal:  J Endocrinol       Date:  2008-04       Impact factor: 4.286

Review 4.  Corticosteroid-induced adverse events in adults: frequency, screening and prevention.

Authors:  Laurence Fardet; Abdulrhaman Kassar; Jean Cabane; Antoine Flahault
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

5.  Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.

Authors:  R I Fisher; E R Gaynor; S Dahlberg; M M Oken; T M Grogan; E M Mize; J H Glick; C A Coltman; T P Miller
Journal:  N Engl J Med       Date:  1993-04-08       Impact factor: 91.245

6.  Adverse effects of oral corticosteroids in relation to dose in patients with lung disease.

Authors:  L J Walsh; C A Wong; J Oborne; S Cooper; S A Lewis; M Pringle; R Hubbard; A E Tattersfield
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

7.  Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.

Authors:  L A Mattano; H N Sather; M E Trigg; J B Nachman
Journal:  J Clin Oncol       Date:  2000-09-15       Impact factor: 44.544

8.  Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group.

Authors:  Lee S Rosen; David Gordon; Simon Tchekmedyian; Ronald Yanagihara; Vera Hirsh; M Krzakowski; M Pawlicki; Paul de Souza; Ming Zheng; Gladys Urbanowitz; Dirk Reitsma; John J Seaman
Journal:  J Clin Oncol       Date:  2003-08-15       Impact factor: 44.544

9.  Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation.

Authors:  Stephanie Campbell; Can-Lan Sun; Seira Kurian; Liton Francisco; Andrea Carter; Sameer Kulkarni; Pablo Parker; Chatchada Karanes; Stephen J Forman; Smita Bhatia
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

Review 10.  The untoward effects of steroid treatment on the musculoskeletal system and what to do about them.

Authors:  J R Hollister
Journal:  J Asthma       Date:  1992       Impact factor: 2.515
View more
  8 in total

1.  Corticosteroid use in neuro-oncology: an update.

Authors:  Patrick Roth; Caroline Happold; Michael Weller
Journal:  Neurooncol Pract       Date:  2014-10-09

2.  Statin use and musculoskeletal pain among adults with and without arthritis.

Authors:  Catherine Buettner; Matthew J Rippberger; Julie K Smith; Suzanne G Leveille; Roger B Davis; Murray A Mittleman
Journal:  Am J Med       Date:  2012-02       Impact factor: 4.965

3.  Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline.

Authors:  X Kostaras; F Cusano; G A Kline; W Roa; J Easaw
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

4.  Cancer Pain: A Critical Review of Mechanism-based Classification and Physical Therapy Management in Palliative Care.

Authors:  Senthil P Kumar
Journal:  Indian J Palliat Care       Date:  2011-05

5.  Pain in blood cancers.

Authors:  Pasquale Niscola; Andrea Tendas; Laura Scaramucci; Marco Giovannini; Vitaliana De Sanctis
Journal:  Indian J Palliat Care       Date:  2011-09

6.  Current practice patterns of osteoporosis treatment in cancer patients and effects of therapeutic interventions in a tertiary center.

Authors:  Nasa Fujihara; Yuki Fujihara; Shunsuke Hamada; Masahiro Yoshida; Satoshi Tsukushi
Journal:  PLoS One       Date:  2021-03-11       Impact factor: 3.240

Review 7.  A Review: The Manifestations, Mechanisms, and Treatments of Musculoskeletal Pain in Patients With COVID-19.

Authors:  Lijuan Wang; Na Yang; Jinfeng Yang; Shuwu Zhao; Chen Su
Journal:  Front Pain Res (Lausanne)       Date:  2022-03-10

8.  Factors related to decreased bone mineral density in childhood cancer survivors.

Authors:  Yun Jung Choi; Sun Young Park; Won Kyoung Cho; Jae Wook Lee; Kyoung Soon Cho; So Hyun Park; Seung Hoon Hahn; Min Ho Jung; Nack Gyun Chung; Bin Cho; Byung Kyu Suh; Hack Ki Kim
Journal:  J Korean Med Sci       Date:  2013-10-31       Impact factor: 2.153
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.